Physician profile
Jarrett H Sutton
NPI 1326244708
$3,441.46
in general payments reported to CMS, 2019-2025
32 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470 · 2020: $216 · 2021: $704 · 2022: $726 · 2023: $681 · 2024: $406 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,325.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $716.08 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Exeltis, USA INC. | $460.12 | 2021-2025 | Slynd |
| Novo Nordisk INC | $317.72 | 2021-2024 | Wegovy |
| Aspira Women'S Health INC | $245.81 | 2023-2024 | Ova1 |
| Pfizer INC. | $228.04 | 2019-2023 | |
| Biogen, INC. | $210.52 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $164.07 | 2019-2022 | |
| Hologic Sales and Service, LLC | $153.38 | 2019-2025 | Aptima |
| Allergan, INC. | $147.73 | 2019 | |
| Organon LLC | $71.35 | 2021-2025 | Nexplanon |
| Shield Therapeutics INC | $68.26 | 2024 | |
| Mayne Pharma Commercial LLC | $61.02 | 2022-2023 | |
| Duchesnay USA Incorporated | $60.39 | 2019 | |
| Millicent US INC | $59.74 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Channel Medsystems, INC. | $55.63 | 2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $51.24 | 2019-2024 | Prolia, Evenity |
| Sumitomo Pharma America, INC. | $37.49 | 2023-2024 | Gemtesa, Myfembree |
| Merck Sharp & Dohme LLC | $31.16 | 2020-2021 | |
| Avion Pharmaceuticals | $30.48 | 2020-2021 | |
| Axonics, INC. | $30.07 | 2021-2023 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $29.24 | 2021-2025 | |
| Aspen Surgical Products, INC. | $27.73 | 2023 | |
| Astellas Pharma US INC | $27.49 | 2020-2024 | Veozah |
| Roche Diagnostics Corporation | $24.66 | 2019 | |
| Meditrina | $23.02 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.88 | 2022 | |
| Becton, Dickinson and Company | $18.29 | 2019 | |
| Gynesonics, INC. | $15.36 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $15.27 | 2022 | |
| Lilly USA, LLC | $12.86 | 2020 | |
| Vertical Pharmaceuticals, LLC | $12.24 | 2019 | |
| Sage Therapeutics, LLC | $12.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarrett Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.